Peering Into Teleflex’s Recent Short Interest
Teleflex’s (NYSE:TFX) short percent of float has risen 46.73% since its last report. The company recently reported that…
Expert Ratings For Teleflex
Throughout the last three months, 4 analysts have evaluated Teleflex (NYSE:TFX), offering a diverse set of opinions from…
How Is The Market Feeling About Teleflex?
Teleflex’s (NYSE:TFX) short percent of float has risen 20.56% since its last report. The company recently reported that…
(TFX) – Analyzing Teleflex’s Short Interest
Teleflex’s (NYSE:TFX) short percent of float has risen 20.56% since its last report. The company recently reported that…
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.
Forecasting The Future: 10 Analyst Projections For Teleflex
Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on Teleflex (NYSE:TFX)…
EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
The Analyst Verdict: Teleflex In The Eyes Of 7 Experts
Across the recent three months, 7 analysts have shared their insights on Teleflex (NYSE:TFX), expressing a variety of…
Analyst Expectations for Teleflex’s Future
Over the past 3 months, 6 analysts have published their opinion on Teleflex (NYSE:TFX) stock. These analysts are…
Teleflex’s Ex-Dividend Date Is Tuesday, Here’s What You Need To Know
Monday marks the last chance for investors to receive the next dividend payout from Teleflex (NYSE:TFX). What’s Happening…